MORI, MATTEO
MORI, MATTEO
Dipartimento di Scienze Farmaceutiche
5,6-Dimethyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole-2,2-dioxide as new STAT3 inhibitor
2019-07-01 S. Villa, M. Mori, F. Meneghetti, A. Pedretti, L. Regazzoni, D. Colombo, A. Asai, A. Gelain
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid
2020-06-18 M. Mori, F. Meneghetti, L.R. Chiarelli, A. Diego, D. Nava, A. Gelain, G. Cazzaniga, S. Villa, E.R.E. Pini
Application of chiral bi- and tetra-dentate bispidine-derived ligands in the copper(II)-catalyzed asymmetric Henry reaction
2018-07-21 A. Rossetti, S. Landoni, F. Meneghetti, C. Castellano, M. Mori, G. Colombo Dugoni, A. Sacchetti
Biocatalysts for the synthesis of pharmacologically active compounds
2020-11-06 S. Ciceri, P. Grisenti, F. Meneghetti, M. Mori, S. Reza Elahi, P. Ferraboschi
Biocatalytic synthesis of two pharmacologically active compounds: (S)-pramipexole and its enantiomer, dexpramipexole.
2020-07-22 S. Ciceri, P. Ferraboschi, P. Grisenti, M. Mori, F. Meneghetti
A click chemistry approach to explore a new scaffold for potential antitubercular agents
2018-09-01 M. Mori, S. Villa, A. Gelain, L.R. Chiarelli, F. Meneghetti
Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps purpurea
2020-01-01 F. Meneghetti, P. Ferraboschi, P. Grisenti, S. Reza Elahi, M. Mori, S. Ciceri
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs
2022-04-01 E. Truzzi, A. Capocefalo, F. Meneghetti, E. Maretti, M. Mori, V. Iannuccelli, F. Domenici, C. Castellano, E. Leo
Design and synthesis of novel antituberculars targeting the salicylate synthase (MbtI)
2017-06-19 S. Villa, L.R. Chiarelli, M. Mori, A. Gelain, L. Costantino, D. Bonanni, T. Tuccinardi, F. Meneghetti
Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents
2017-01-01 M. Mori, S. Villa, L.R. Chiarelli, A. Gelain, L. Costantino, T. Tuccinardi, M. Lapillo, F. Meneghetti
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI).
2018-01-01 S. Villa, L.R. Chiarelli, M. Mori, D. Barlocco, A. Gelain, E. Pini, G. Mori, L. Costantino, T. Tuccinardi, F. Meneghetti
Diazabicyclo analogues of maraviroc : synthesis, modeling, NMR studies and antiviral activity
2017-02-01 L. Legnani, D. Colombo, A. Venuti, C. Pastori, L. Lopalco, L. Toma, M. Mori, G. Grazioso, S. Villa
Discovery and development of novel salicylate synthase (MbtI) Furanic inhibitors as antitubercular agents
2018-07-15 L.R. Chiarelli, M. Mori, D. Barlocco, G. Beretta, A. Gelain, E. Pini, M. Porcino, G. Mori, G. Stelitano, L. Costantino, M. Lapillo, D. Bonanni, G. Poli, T. Tuccinardi, S. Villa, F. Meneghetti
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors : Design, Synthesis, Inhibition Mechanism and in Vitro Efficacy against Melanoma Cell Lines
2019-08-08 C. Cerchia, R. Nasso, M. Mori, S. Villa, A. Gelain, A. Capasso, F. Aliotta, M. Simonetti, R. Rullo, M. Masullo, E. De Vendittis, M.R. Ruocco, A. Lavecchia
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation
2019-04-01 E. Truzzi, F. Meneghetti, M. Mori, L. Costantino, V. Iannuccelli, E. Maretti, F. Domenici, C. Castellano, S. Rogers, A. Capocefalo, E. Leo
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2019-01-01 A. Gelain, M. Mori, F. Meneghetti, F. Porta, L. Basile, G. Marverti, A. Asai, M. Hyeraci, A.N. García-Argáez, L.D. Via, S. Guccione, S. Villa
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MBTI from mycobacterium tuberculosis
2019-07-17 M. Mori, L. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti, S. Villa
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity
2022-05-03 E.M.A. Fassi, M. Garofalo, J. Sgrignani, M.V. DEI CAS, M. Mori, G. Roda, A. Cavalli, G. Grazioso
Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen cortexolone 17α-propionate for topic application
2017-01-01 P. Ferraboschi, M. Sala, R. Stradi, L. Ragonesi, C. Gagliardi, P. Lanzarotti, E..M. Ragg, M. Mori, F. Meneghetti
Functionalized nanoparticles as potential antibiofilm agents
2021-06-23 A. Gelain, M. Mori, F. Meneghetti, P. Molino, P. Hayes, S. Villa